RP

Rekha Praveen Jain

Active Director Designated Partner DIN 05004417
DIN 05004417 First appointment Feb 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Rekha Praveen Jain

Data last updated:

Rekha Praveen Jain is a Designated Partner at Accrete Critical Care International Llp (since 2010). The company operates in Healthcare.

DIN 05004417
Primary Designation Designated Partner
Industry Healthcare
First Appointment 10 Feb 2010
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Feb 20102010Active

Board colleagues of Rekha Praveen Jain

NameDINCompanyDesignation
Praveen Kumar Jain05004416Accrete Critical Care International LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Accrete Critical Care International Llp
Premium access

Shareholding and investment profile for Rekha Praveen Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Praveen Jain

Rekha Praveen Jain currently holds 1 directorship: Accrete Critical Care International Llp (Designated Partner, since 10 Feb 2010).

Rekha Praveen Jain was first appointed on 10 Feb 2010 as Designated Partner at Accrete Critical Care International Llp.

The current boards of Rekha Praveen Jain's companies include Praveen Kumar Jain (Accrete Critical Care International Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available